LONZA GROUP

World Rank (Jul-30-2023)
414
Market Cap (Jul-30-2023)
44.01 Billion USD
World Rank (Dec-25-2022)
460
Market Cap (Dec-25-2022)
36.08 Billion USD
World Rank (Jan-07-2022)
316
Market Cap (Jan-07-2022)
57.618 Billion USD
World Rank (Jan-01-2021)
345
Market Cap (Jan-01-2021)
47.276 Billion USD
Annual Revenue in USD
7,148 Million USD
Annual Net Income in USD
1,396 Million USD
Total Assets in USD
19,937 Million USD
Total Liabilities in USD
7,686 Million USD
Annual Results for Year ending in
Dec-2022 month
Headquarters Country
Switzerland
Headquarters Sub Region
Western Europe
Headquarters Continent
Europe
Company Business
Healthcare
Pharmaceutical
Biopharmaceutical
Chemicals
Biotechnology
Stock Category
S&P EUROPE 350
Stock Exchange
Switzerland
Company Rank in Country in 2022
Company Rank in Switzerland in 2022 is 11
Rank in Country (Jan-2021)
Company Rank in Switzerland in 2021 is 9
Number of Employees
17,500
Employee Count as on Date
As on 2023
Chairman
Albert M. Baehny
CEO:
Pierre-Alain Ruffieux
Yahoo @ Switzerland
Wikipedia
Facebook
Company Website:
LONZA GROUP AG
Business Sector:
Top Healthcare Companies in Europe
Top Technology Companies in Europe
Top Pharmaceutical Companies in Europe
About Company Business:

Pharmaceutical, Bio Technology and Chemical Company with headquarters in Basel, Switzerland.

Founded Year
1897
Annual Results Summary:

LONZA GROUP - Annual Results - Revenue and Net Income - in Million CHF:

Year - Ending Revenue Net Income
Dec-2022 6,223 1,215
Dec-2021 5,409 2,944
Dec-2020 4,508 869
Dec-2019 5,920 645
Dec-2018 5,542 559
Balance Sheet Summary

Total Assets as on Dec-2022 was 17,356 Million CHF.

Total Liabilities as on Dec-2022 was 6,691 Million CHF.

Total Equity as on Dec-2022 was 10,665 Million CHF.

Share it on Social Media